A64 BRONCHOPULMONARY DYSPLASIA: Treprostinil Use For Pulmonary Hypertension In Congenital Diaphragmatic Hernia

A64 BRONCHOPULMONARY DYSPLASIA: Treprostinil Use For Pulmonary Hypertension In Congenital Diaphragmatic Hernia

Rationale: Pulmonary hypertension (PH) is the leading cause of morbidity and mortality among children with congenital diaphragmatic hernia (CDH). There was no significant change in inhaled nitric oxide dose, oxygen requirement or ventilator support after treprostinil initiation.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Hauptverfasser: Lawrence, K M, Holly, H L, Herkert, L, Waqar, L N, Bodenstab, H M, Hanna, B, Peranteau, W H, Rintoul, N E, Hopper, R K
Format: Artikel
Sprache:eng
Schlagworte:
Hernias
Lung diseases
Mortality
Population
Pulmonary hypertension
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Rationale: Pulmonary hypertension (PH) is the leading cause of morbidity and mortality among children with congenital diaphragmatic hernia (CDH). There was no significant change in inhaled nitric oxide dose, oxygen requirement or ventilator support after treprostinil initiation.
ISSN:1073-449X
1535-4970